Anju Sharma

Anju Sharma

Auto-generated profile, based on publicly available information

Anju Sharma

AMITY Institute of Biotechnology, AMITY University Uttar Pradesh, Lucknow-226028, Uttar Pradesh, India

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 August 2019 in Current Neuropharmacology
Verified
Journal Article
Open access
ASAnju Sharma
Anju Sharma
RKRajnish Kumar
Rajnish Kumar
IAImlimaong Aier
Imlimaong Aier
RSRahul Semwal
Rahul Semwal
PTPankaj Tyagi
Pankaj Tyagi
PVPRITISH VARADWAJ
PRITISH VARADWAJ
Olfaction, the sense of smell detects and discriminate odors as well as social cues which influence our innate responses. The olfactory system in human beings is found to be weak as compared to other animals; however, it seems to be very precise. It can detect and discriminate millions of chemical moieties (odorants) even in minuscule quantities. The process initiates with the binding of odorants to specialized olfactory receptors, encoded by a large family of Olfactory Receptor (OR) genes belonging to the G-protein-coupled receptor superfamily. Stimulation of ORs converts the chemical information encoded in the odorants, into respective neuronal action-potentials which causes depolarization of olfactory sensory neurons. The olfactory bulb relays this signal to different parts of the brain for processing. Odors are encrypted using a combinatorial approach to detect a variety of chemicals and encode their unique identity. The discovery of functional OR genes and proteins provided an important information to decipher the genomic, structural and functional basis of olfaction. ORs constitute 17 gene families, out of which 4 families were reported to contain more than hundred members each. The olfactory machinery is not limited to GPCRs; a number of non- GPCRs is also employed to detect chemosensory stimuli. The article provides detailed information about such olfaction machinery, structures, transduction mechanism, theories of odor perception, and challenges in the olfaction research. It covers the structural, functional and computational studies carried out in the olfaction research in the recent past.

1 February 2019 in Cancer Epidemiology
Verified
Journal Article
Closed access
IAImlimaong Aier
Imlimaong Aier
RSRahul Semwal
Rahul Semwal
ASAnju Sharma
Anju Sharma
PVPRITISH VARADWAJ
PRITISH VARADWAJ

15 January 2021 in Journal of Chemical Information and Modeling
Verified
Journal Article
Closed access
ASAnju Sharma
Anju Sharma
RKRajnish Kumar
Rajnish Kumar
SRShabnam Ranjta
Shabnam Ranjta
PVPRITISH VARADWAJ
PRITISH VARADWAJ

27 October 2017 in Current Drug Discovery Technologies
Verified
Journal Article
Closed access
RKRajnish Kumar
Rajnish Kumar
ASAnju Sharma
Anju Sharma
MSMohammed Haris Siddiqui
Mohammed Haris Siddiqui
RTRajesh Kumar Tiwari
Rajesh Kumar Tiwari
Background: Information about Pharmacokinetics of compounds is an essential component of drug design and development. Modeling the pharmacokinetic properties require identification of the factors effecting absorption, distribution, metabolism and excretion of compounds. There have been continuous attempts in the prediction of intestinal absorption of compounds using various Artificial intelligence methods in the effort to reduce the attrition rate of drug candidates entering to preclinical and clinical trials. Currently, there are large numbers of individual predictive models available for absorption using machine learning approaches. Methods: Six Artificial intelligence methods namely, Support vector machine, k- nearest neighbor, Probabilis-tic neural network, Artificial neural network, Partial least square and Linear discriminant analysis were used for prediction of absorption of compounds. Results: Prediction accuracies of Support vector machine, k- nearest neighbor, Probabilistic neural network, Ar-tificial neural network, Partial least square and Linear discriminant analysis for prediction of intestinal absorp-tion of compounds was found to be 91.54%, 88.33%, 84.30%, 86.51%, 79.07% and 80.08% respectively. Conclusion: Comparative analysis of all the six prediction models suggested that Support vector machine with Radial basis function based kernel is comparatively better for binary classification of compounds using human intestinal absorption and may be useful at preliminary stages of drug design and development.

15 January 2020 in Current Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
RKRajnish Kumar
Rajnish Kumar
ASAnju Sharma
Anju Sharma
MIMohammed Shariq Iqbal
Mohammed Shariq Iqbal
JSJanmejai K. Srivastava
Janmejai K. Srivastava
Background:: Chlorogenic acid (CGA) is a quinic acid conjugate of caffeic acid. It is an ester formed between caffeic acid and the 3-hydroxyl of L-quinic acid. This polyphenol is naturally present in substantial amount in the green coffee beans. Minor quantities of CGA are also reported in apples, eggplant, blueberries, tomatoes, strawberries and potatoes. CGA is reported to be beneficial in hypertension, hyperglycemia, antimicrobial, antitumor, memory enhancer, weight management etc. Further, it is also reported to have anticancer, antioxidant and anti-inflammatory activities. Since the last decade, CGA drew public attention for its widely recommended use as a medicine or natural food additive supplement for the management of obesity. Objective: The current review explores the medicinal promises of CGA and emphasizes on its antiobese property as reported by various scientific reports and publication. Conclusion: CGA shows promises as an antioxidant, glycemic control agent, anti-hypertensive, antiinflammatory, antimicrobial, neuro-protective and anti-obesity agent. It primarily activates the AMPactivated protein kinase, inhibits 3-hydroxy 3-methylglutaryl coenzyme-A reductase and strengthens the activity of carnitine palmitoyltransferase to control the obesity.

1 January 2012 in Journal of Pharmacy and Bioallied Sciences
Verified
Journal Article
Open access
PDF file
RKRajnish Kumar
Rajnish Kumar
ASAnju Sharma
Anju Sharma
RTRajesh Kumar Tiwari
Rajesh Kumar Tiwari
There are more than 1.15 million cases of breast cancer diagnosed worldwide annually. At present, only small numbers of accurate prognostic and predictive factors are used clinically for managing the patients with breast cancer. DNA microarrays have the potential to assess the expression of thousands of genes simultaneously. Recent preliminary researches indicate that gene expression profiling based on DNA microarray can offer potential and independent prognostic information in patients with newly diagnosed breast cancer. In this paper, an overview upon the applications of microarray techniques in breast cancer is presented.